Biotech developing kidney disease treatment jumps after hedge fund recommendation at conference
May 06, 2019 at 15:26 PM EDT
Bihua Chen, founder and portfolio manager at Cormorant Asset Management, said on Monday she likes kidney drugmaker Reata Pharmaceutical.